EVOLENT HEALTH INC - A (EVH) Fundamental Analysis & Valuation

NYSE:EVH • US30050B1017

2.995 USD
-0.17 (-5.52%)
Last: Mar 9, 2026, 12:17 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EVH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EVH. EVH was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of EVH have multiple concerns. EVH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. EVH Profitability Analysis

1.1 Basic Checks

  • In the past year EVH was profitable.
  • In the past year EVH had a positive cash flow from operations.
  • EVH had negative earnings in each of the past 5 years.
  • EVH had a positive operating cash flow in 4 of the past 5 years.
EVH Yearly Net Income VS EBIT VS OCF VS FCFEVH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • EVH has a worse Return On Assets (-30.51%) than 60.00% of its industry peers.
  • EVH has a Return On Equity of -139.55%. This is in the lower half of the industry: EVH underperforms 74.29% of its industry peers.
Industry RankSector Rank
ROA -30.51%
ROE -139.55%
ROIC N/A
ROA(3y)-13.16%
ROA(5y)-8.64%
ROE(3y)-52.94%
ROE(5y)-33.29%
ROIC(3y)N/A
ROIC(5y)N/A
EVH Yearly ROA, ROE, ROICEVH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • The Gross Margin of EVH (21.31%) is worse than 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of EVH has declined.
  • The Profit Margin and Operating Margin are not available for EVH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.09%
GM growth 5Y-2.88%
EVH Yearly Profit, Operating, Gross MarginsEVH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. EVH Health Analysis

2.1 Basic Checks

  • EVH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for EVH has been reduced compared to 1 year ago.
  • Compared to 5 years ago, EVH has more shares outstanding
  • Compared to 1 year ago, EVH has a worse debt to assets ratio.
EVH Yearly Shares OutstandingEVH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EVH Yearly Total Debt VS Total AssetsEVH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • EVH has an Altman-Z score of 0.22. This is a bad value and indicates that EVH is not financially healthy and even has some risk of bankruptcy.
  • EVH has a Altman-Z score (0.22) which is in line with its industry peers.
  • EVH has a debt to FCF ratio of 204.11. This is a negative value and a sign of low solvency as EVH would need 204.11 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 204.11, EVH is in line with its industry, outperforming 48.57% of the companies in the same industry.
  • A Debt/Equity ratio of 2.34 is on the high side and indicates that EVH has dependencies on debt financing.
  • EVH has a Debt to Equity ratio of 2.34. This is amonst the worse of the industry: EVH underperforms 88.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 204.11
Altman-Z 0.22
ROIC/WACCN/A
WACC7.54%
EVH Yearly LT Debt VS Equity VS FCFEVH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that EVH should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.31, EVH is doing worse than 65.71% of the companies in the same industry.
  • A Quick Ratio of 1.31 indicates that EVH should not have too much problems paying its short term obligations.
  • The Quick ratio of EVH (1.31) is worse than 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
EVH Yearly Current Assets VS Current LiabilitesEVH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EVH Growth Analysis

3.1 Past

  • EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.36%.
  • EVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.75% yearly.
  • The Revenue for EVH has decreased by -26.56% in the past year. This is quite bad
  • Measured over the past years, EVH shows a quite strong growth in Revenue. The Revenue has been growing by 15.20% on average per year.
EPS 1Y (TTM)-86.36%
EPS 3Y-53.75%
EPS 5YN/A
EPS Q2Q%500%
Revenue 1Y (TTM)-26.56%
Revenue growth 3Y11.54%
Revenue growth 5Y15.2%
Sales Q2Q%-27.5%

3.2 Future

  • Based on estimates for the next years, EVH will show a very strong growth in Earnings Per Share. The EPS will grow by 64.70% on average per year.
  • EVH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.60% yearly.
EPS Next Y201.88%
EPS Next 2Y123.95%
EPS Next 3Y101.54%
EPS Next 5Y64.7%
Revenue Next Year31.72%
Revenue Next 2Y23.62%
Revenue Next 3Y20.59%
Revenue Next 5Y18.6%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EVH Yearly Revenue VS EstimatesEVH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EVH Yearly EPS VS EstimatesEVH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. EVH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 33.28 indicates a quite expensive valuation of EVH.
  • Based on the Price/Earnings ratio, EVH is valued a bit cheaper than the industry average as 68.57% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.29. EVH is valued slightly more expensive when compared to this.
  • Based on the Price/Forward Earnings ratio of 11.02, the valuation of EVH can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, EVH is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
  • EVH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.60.
Industry RankSector Rank
PE 33.28
Fwd PE 11.02
EVH Price Earnings VS Forward Price EarningsEVH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 77.14% of the companies in the same industry are more expensive than EVH, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EVH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 70.32
EV/EBITDA 11.18
EVH Per share dataEVH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • EVH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EVH's earnings are expected to grow with 101.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y123.95%
EPS Next 3Y101.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EVH Dividend Analysis

5.1 Amount

  • EVH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EVH Fundamentals: All Metrics, Ratios and Statistics

EVOLENT HEALTH INC - A

NYSE:EVH (3/9/2026, 12:17:58 PM)

2.995

-0.17 (-5.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-24
Earnings (Next)05-06
Inst Owners110.54%
Inst Owner Change-12.28%
Ins Owners2.1%
Ins Owner Change3.82%
Market Cap334.36M
Revenue(TTM)1.88B
Net Income(TTM)-579.40M
Analysts83
Price Target8.89 (196.83%)
Short Float %18.55%
Short Ratio6.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.5%
Min EPS beat(2)-52.63%
Max EPS beat(2)37.63%
EPS beat(4)1
Avg EPS beat(4)-69.8%
Min EPS beat(4)-226.45%
Max EPS beat(4)37.63%
EPS beat(8)3
Avg EPS beat(8)-80.44%
EPS beat(12)7
Avg EPS beat(12)-19.32%
EPS beat(16)10
Avg EPS beat(16)391.59%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)4
Avg Revenue beat(8)0.35%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)-4.69%
PT rev (3m)-14.39%
EPS NQ rev (1m)-89.8%
EPS NQ rev (3m)-89.23%
EPS NY rev (1m)-22.65%
EPS NY rev (3m)-22.94%
Revenue NQ rev (1m)-2.48%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)3.87%
Revenue NY rev (3m)2.46%
Valuation
Industry RankSector Rank
PE 33.28
Fwd PE 11.02
P/S 0.18
P/FCF 70.32
P/OCF 8.61
P/B 0.81
P/tB N/A
EV/EBITDA 11.18
EPS(TTM)0.09
EY3.01%
EPS(NY)0.27
Fwd EY9.07%
FCF(TTM)0.04
FCFY1.42%
OCF(TTM)0.35
OCFY11.62%
SpS16.81
BVpS3.72
TBVpS-7.74
PEG (NY)0.16
PEG (5Y)N/A
Graham Number2.74
Profitability
Industry RankSector Rank
ROA -30.51%
ROE -139.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.31%
FCFM 0.25%
ROA(3y)-13.16%
ROA(5y)-8.64%
ROE(3y)-52.94%
ROE(5y)-33.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.09%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 204.11
Debt/EBITDA 9.25
Cap/Depr 29.42%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion 37.02%
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 0.22
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)24.58%
Cap/Depr(5y)37.22%
Cap/Sales(3y)1.42%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.36%
EPS 3Y-53.75%
EPS 5YN/A
EPS Q2Q%500%
EPS Next Y201.88%
EPS Next 2Y123.95%
EPS Next 3Y101.54%
EPS Next 5Y64.7%
Revenue 1Y (TTM)-26.56%
Revenue growth 3Y11.54%
Revenue growth 5Y15.2%
Sales Q2Q%-27.5%
Revenue Next Year31.72%
Revenue Next 2Y23.62%
Revenue Next 3Y20.59%
Revenue Next 5Y18.6%
EBIT growth 1Y-324.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.7%
EBIT Next 3Y28.67%
EBIT Next 5Y21.36%
FCF growth 1Y177.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107%
OCF growth 3YN/A
OCF growth 5YN/A

EVOLENT HEALTH INC - A / EVH FAQ

What is the fundamental rating for EVH stock?

ChartMill assigns a fundamental rating of 3 / 10 to EVH.


Can you provide the valuation status for EVOLENT HEALTH INC - A?

ChartMill assigns a valuation rating of 6 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Fairly Valued.


Can you provide the profitability details for EVOLENT HEALTH INC - A?

EVOLENT HEALTH INC - A (EVH) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for EVH stock?

The Price/Earnings (PE) ratio for EVOLENT HEALTH INC - A (EVH) is 33.28 and the Price/Book (PB) ratio is 0.81.


Can you provide the financial health for EVH stock?

The financial health rating of EVOLENT HEALTH INC - A (EVH) is 2 / 10.